Dr. Rizvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 James P Murphy Ind Hwy
Ste 102
West Warwick, RI 02893
Education & Training
- Stony Brook Medicine/University HospitalResidency, Neurology, 1998 - 1999
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1994 - 1998
- Stony Brook Medicine/University HospitalResidency, Neurology, 1994 - 1997
- Stony Brook Medicine/University HospitalResidency, Neurology, 1993 - 1994
- AtlantiCare Regional Medical CenterInternship, Internal Medicine, 1992 - 1993
- Dow University of Health SciencesClass of 1991
Certifications & Licensure
- RI State Medical License 2001 - 2026
- NY State Medical License 1999 - 2002
- PA State Medical License 1993 - 1994
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Clinical Trials
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 25 citationsThe association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosisGraham D. Cochrane, Syed A. Rizvi, Ana M. Abrantes, Brigid Crabtree, Jonathan Cahill
Parkinsonism & Related Disorders. 2015-09-01 - 3 citationsCardiac sarcoidosis requiring ICD placement and immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis.Natalie Erlich-Malona, Jonathan Cahill, Saima Chaudhry, Janice Martin, Syed A. Rizvi
Multiple Sclerosis and Related Disorders. 2021-01-01 - 3 citationsThe Lived Experiences of Adults with Multiple Sclerosis.Kayla K Haubrick, Emily A Gadbois, Susan E. Campbell, Jessica Young, Tingting Zhang
Rhode Island Medical Journal. 2021-08-02
Press Mentions
- Dr. Rizvi on Treatment Considerations in Stage III/IV Hodgkin LymphomaFebruary 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: